In vitro killing of human malignant mesothelioma by photodynamic therapy

Steven M. Keller, Douglas D. Taylor, James L. Weese

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Photodynamic therapy was investigated as a potential new modality for the treatment of human malignant mesothelioma (HMM) utilizing the H-MESO-1 HMM cell line and the photosensitizing agent, Photofrin-II (PF-II). Uptake of PF-II by H-MESO-1 was documented by incubating H-MESO-1 cells with PF-II and measuring the fluorescence at 625 nm following excitation at 400 nm. Cytotoxicity of photodynamic therapy was determined by incubating H-MESO-1 cells (2 × 105) in microtiter plates for 24 hr with concentrations of PF-II varying from 0 to 10 pg/ml. The wells were exposed to gold vapor laser light (628 nm) in doses ranging from 0 to 24,000 J/m2. Twenty-four hours following treatment, [3h]thymidine (1 μCi) was added to each well. Cells were harvested 24 hr later and counted for tritium incorporation. Five replicates were performed for each combination of light and drug. Peak absorption of PF-II by HMESO-1 was reached within 8 hr. Maximal doses of light alone caused minimal cell killing. PF-II without light was cytotoxic only at the highest concentrations. However, the combination of PF-II at concentrations at or above 2.5 μg/ml and light produced a significant increase in cytotoxicity. These data demonstrate that photodynamic therapy can effectively kill human malignant mesothelioma cells in vitro.

Original languageEnglish (US)
Pages (from-to)337-340
Number of pages4
JournalJournal of Surgical Research
Volume48
Issue number4
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Dihematoporphyrin Ether
Photochemotherapy
Light
Photosensitizing Agents
Gas Lasers
Tritium
Drug Combinations
Malignant Mesothelioma
In Vitro Techniques
Thymidine
Fluorescence
Cell Line
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

In vitro killing of human malignant mesothelioma by photodynamic therapy. / Keller, Steven M.; Taylor, Douglas D.; Weese, James L.

In: Journal of Surgical Research, Vol. 48, No. 4, 1990, p. 337-340.

Research output: Contribution to journalArticle

Keller, Steven M. ; Taylor, Douglas D. ; Weese, James L. / In vitro killing of human malignant mesothelioma by photodynamic therapy. In: Journal of Surgical Research. 1990 ; Vol. 48, No. 4. pp. 337-340.
@article{709676f24db841f58db744505282029a,
title = "In vitro killing of human malignant mesothelioma by photodynamic therapy",
abstract = "Photodynamic therapy was investigated as a potential new modality for the treatment of human malignant mesothelioma (HMM) utilizing the H-MESO-1 HMM cell line and the photosensitizing agent, Photofrin-II (PF-II). Uptake of PF-II by H-MESO-1 was documented by incubating H-MESO-1 cells with PF-II and measuring the fluorescence at 625 nm following excitation at 400 nm. Cytotoxicity of photodynamic therapy was determined by incubating H-MESO-1 cells (2 × 105) in microtiter plates for 24 hr with concentrations of PF-II varying from 0 to 10 pg/ml. The wells were exposed to gold vapor laser light (628 nm) in doses ranging from 0 to 24,000 J/m2. Twenty-four hours following treatment, [3h]thymidine (1 μCi) was added to each well. Cells were harvested 24 hr later and counted for tritium incorporation. Five replicates were performed for each combination of light and drug. Peak absorption of PF-II by HMESO-1 was reached within 8 hr. Maximal doses of light alone caused minimal cell killing. PF-II without light was cytotoxic only at the highest concentrations. However, the combination of PF-II at concentrations at or above 2.5 μg/ml and light produced a significant increase in cytotoxicity. These data demonstrate that photodynamic therapy can effectively kill human malignant mesothelioma cells in vitro.",
author = "Keller, {Steven M.} and Taylor, {Douglas D.} and Weese, {James L.}",
year = "1990",
doi = "10.1016/0022-4804(90)90070-I",
language = "English (US)",
volume = "48",
pages = "337--340",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - In vitro killing of human malignant mesothelioma by photodynamic therapy

AU - Keller, Steven M.

AU - Taylor, Douglas D.

AU - Weese, James L.

PY - 1990

Y1 - 1990

N2 - Photodynamic therapy was investigated as a potential new modality for the treatment of human malignant mesothelioma (HMM) utilizing the H-MESO-1 HMM cell line and the photosensitizing agent, Photofrin-II (PF-II). Uptake of PF-II by H-MESO-1 was documented by incubating H-MESO-1 cells with PF-II and measuring the fluorescence at 625 nm following excitation at 400 nm. Cytotoxicity of photodynamic therapy was determined by incubating H-MESO-1 cells (2 × 105) in microtiter plates for 24 hr with concentrations of PF-II varying from 0 to 10 pg/ml. The wells were exposed to gold vapor laser light (628 nm) in doses ranging from 0 to 24,000 J/m2. Twenty-four hours following treatment, [3h]thymidine (1 μCi) was added to each well. Cells were harvested 24 hr later and counted for tritium incorporation. Five replicates were performed for each combination of light and drug. Peak absorption of PF-II by HMESO-1 was reached within 8 hr. Maximal doses of light alone caused minimal cell killing. PF-II without light was cytotoxic only at the highest concentrations. However, the combination of PF-II at concentrations at or above 2.5 μg/ml and light produced a significant increase in cytotoxicity. These data demonstrate that photodynamic therapy can effectively kill human malignant mesothelioma cells in vitro.

AB - Photodynamic therapy was investigated as a potential new modality for the treatment of human malignant mesothelioma (HMM) utilizing the H-MESO-1 HMM cell line and the photosensitizing agent, Photofrin-II (PF-II). Uptake of PF-II by H-MESO-1 was documented by incubating H-MESO-1 cells with PF-II and measuring the fluorescence at 625 nm following excitation at 400 nm. Cytotoxicity of photodynamic therapy was determined by incubating H-MESO-1 cells (2 × 105) in microtiter plates for 24 hr with concentrations of PF-II varying from 0 to 10 pg/ml. The wells were exposed to gold vapor laser light (628 nm) in doses ranging from 0 to 24,000 J/m2. Twenty-four hours following treatment, [3h]thymidine (1 μCi) was added to each well. Cells were harvested 24 hr later and counted for tritium incorporation. Five replicates were performed for each combination of light and drug. Peak absorption of PF-II by HMESO-1 was reached within 8 hr. Maximal doses of light alone caused minimal cell killing. PF-II without light was cytotoxic only at the highest concentrations. However, the combination of PF-II at concentrations at or above 2.5 μg/ml and light produced a significant increase in cytotoxicity. These data demonstrate that photodynamic therapy can effectively kill human malignant mesothelioma cells in vitro.

UR - http://www.scopus.com/inward/record.url?scp=0025368014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025368014&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(90)90070-I

DO - 10.1016/0022-4804(90)90070-I

M3 - Article

C2 - 2140142

AN - SCOPUS:0025368014

VL - 48

SP - 337

EP - 340

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 4

ER -